Essential Perspectives: Focus on Hemophilia/ASH 2013 Annual Meeting
This activity presents key findings from 4 poster presentations: including 2 on emerging long-half-life clotting factor replacements, as well as data on the long-term safety of an existing clotting factor replacement, and a novel immunosuppressive regimen for acquired hemophilia A, presented at the American Society of Hematology Annual Meeting held in New Orleans, Louisiana from December 7-10, 2013
This activity was developed for hematologists and other clinicians who treat patients with hemophilia.
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance